We use cookies for a better user experience. Read our Privacy Policy

I Agree

Hepatitis E Diagnostic Tests Market Forecast Report, 2019-2027

Hepatitis E Diagnostic Tests Market (Test Type - ELISA HEV IgM Test kits, ELISA HEV IgG Test Kits, and RT-PCR Test Kits; End User - Hospitals, Diagnostic Laboratories, Research Centers, and Point of Care) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2019 - 2027

Hepatitis E Diagnostic Tests Market - Snapshot

Hepatitis E is an enteric-transmitted liver disease induced by the hepatitis E virus (HEV). This is one of the five human hepatitis viruses that have been identified (A, B, C, D, and E). Hepatitis E is transmitted via fecal-oral contact due to contamination of drinking water with feces. Vertical transmission from a pregnant woman to her baby, transfusion of contaminated blood products, and eating of undercooked meat and/or meat products produced from infected animals are the additional ways of spread of hepatitis E virus. In areas where sanitation is inadequate, hepatitis E virus infections are widespread, which is likely to benefit development of the global hepatitis e diagnostic tests market in the forthcoming years.

Hepatitis E patients are difficult to identify from other kinds of viral hepatitis. As a result, the detection of RNA and antibodies against HEV can be used to confirm the diagnosis. Indirect tests are the tests conducted to detect the existence of IgG and IgM, while tests for the existence of HEV RNA are called direct tests. The existence of IgM is the primary test for detecting severe infections in patients, which is then validated by RNA testing. If IgG antibodies are present, then the patient has already been infected with the hepatitis E virus.

Rise in the Incidences of Hepatitis E Globally to Drive Growth of the Market

The global hepatitis e diagnostic tests market is being propelled by rising public awareness about the need of early HEV detection. IgG titers in the sample set imply that the person has been infected with HEV earlier. According to the WHO, there are over 20.1 million instances of infection globally, with over 3.3 million of them being symptomatic, resulting in over 70,000 fatalities and 3,000 stillbirths.

In the hepatitis E diagnostic tests market, research institutions and diagnostic laboratories are likely to see significant expansion. The rising sero-prevalence of hepatitis E, which was formerly thought to be a silent illness, has prompted further research into the disease's transmission mechanisms, resulting in the development of research institutions. In addition to that, research is being undertaken on the severe sequelae of hepatitis E, as well as the method of infection of distinct genotypes of hepatitis E, all of which contribute to research institutes' revenue share in the global hepatitis e diagnostic tests market.​​​

  • According to Transparency Market Research’s latest report on the global hepatitis E diagnostic tests market for the historical period 2017–2018 and forecast period 2019–2027, increase awareness among people related to the early diagnosis of hepatitis E, owing to the hyper-endemicity of the disease in certain regions and the growing tourism, leading to the movement of people from hyper-endemic and endemic regions to non-endemic regions are some factors driving the market.
  • According to the report, the global hepatitis E diagnostic tests market was valued at US$ 47.8 Mn in 2018 and is anticipated to expand at a CAGR of 4.5% from 2019 to 2027.

Request a sample to get extensive insights into the Hepatitis E Diagnostic Tests Market.

Movement of people from hyper-endemic and endemic regions to non-endemic regions: A Key Driver

  • The growth of hepatitis E diagnostic tests market in Latin America is expected to be modest, owing to the hyper-endemicity of the disease in certain regions and the growing tourism, leading to the movement of people from hyper-endemic and endemic regions to non-endemic regions. For instance, Brazil, Argentina, Peru, and Chile among others are the major tourist destinations in Latin America, attracting tourists from all over the world. In addition, the 2016 Rio Olympics was a major event which attracted major tourists in the region. This has contributed to the movement of tourists to these non-endemic countries in Latin America. Furthermore, hepatitis E is hyper-endemic in Uruguay, Venezuela, Cuba, and Mexico contributing to the growth of hepatitis E diagnostic tests market. In addition, according to WHO/UNICEF Joint Monitoring Programme 2015, more than 106 million people in Latin America live in places without access to proper sanitation. These factors contribute to the spread of hepatitis E, contributing to the growth in the demand for diagnosis, positively leading the growth of hepatitis E diagnostic tests market.

Unfavorable reimbursement policies to Hamper Global Hepatitis E Diagnostic Tests Market

  • Product offering at relatively lower than average selling price has increased market penetration of local players having wide distribution network in certain geographies This is imposing pricing pressure on major manufacturers, thereby intensifying competition. Dominance of local players offering a wide range of reagents portfolio at lower rates is hampering the geographic expansion of major players in particular regions.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Asia Pacific to Account for Major Share of Global Hepatitis E Diagnostic Tests Market

  • Asia Pacific was the dominant region in hepatitis E diagnostic tests market and is expected to remain dominant during the forecast period. Asia Pacific and Middle East and Africa, accounted for a combined market share of more than 60% in 2018. The hyper-endemicity of hepatitis E in various countries of Asia Pacific such as India, Pakistan, Nepal, Bhutan, Bangladesh, Vietnam, Thailand, Kazakhstan, and Burma, among others; and in various countries of Africa, such as Uganda, Kenya, Morocco, and Nigeria, among others contribute to the high revenue share of these regions in hepatitis E diagnostic tests market. North America, and Europe which are the developed regions, do not have significant prevalence of hepatitis E, as this disease is found to be more prevalent in the regions with poor sanitation facilities and with lack of safe drinking water.  In Europe, pork consumption is the highest, indicating the zoonotic mode of transmission of the disease, as swine is considered to be the primary carrier of HEV.

Global Hepatitis E diagnostic tests Market: Competitive Landscape

  • This report profiles major players in the global hepatitis E diagnostic tests market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • Key players operating in the hepatitis E diagnostic tests market include
    • altona Diagnostics GmbH
    • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
    • Biokit S.A.
    • Dia.Pro - Diagnostic Bioprobes s.r.l, F. Hoffmann-La Roche Ltd.
    • Fast-track diagnostics Ltd.
    • Fortress Diagnostics Limited
    • Mikrogen GmBH
    • MP Biomedicals
    • LLC.
    • Primerdesign Ltd.
    • among others.
  • Several major manufacturers are collaborating, partnering, acquiring emerging market entrants having novel products. This amalgamation of technical expertise of key players and novel product techniques or materials of new players has ensured launch of new products with improved functionalities in the next few years.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Hepatitis E Diagnostic Tests Market.

Global Hepatitis E Diagnostic Tests Market: Key Developments

Players in the hepatitis E diagnostic tests market are focused on investing in research and development to develop newer devices with enhanced technology which would enable clinicians to perform serological tests for anti-HEV in a single-test format to diagnose the pathology reliably and quickly (40 minutes). This would help the companies to strengthen their market positions.

  • In June 2019, BioMérieux has expanded its hepatitis panel, which already included diagnostic tests for hepatitis A, B and C, with the launch of two VIDAS hepatitis E tests. This will enable the company to strengthen its leadership position in the hepatitis E diagnostic device market.

The report on the global hepatitis E diagnostic tests market discusses individual strategies followed by company profiles of manufacturers of hepatitis E diagnostic tests treatment products. The competitive landscape section has been included in the hepatitis E diagnostic tests market report to provide readers with a dashboard view and a company hepatitis E diagnostic tests market share analysis of key players operating in the global Hepatitis E diagnostic tests market.

Global Hepatitis E Diagnostic Tests Market - Segmentation

Test Type

  • ELISA HEV IgM Test kits
  • ELISA HEV IgG Test kits
  • RT-PCR Test kits
  • Others

End-user

  • Hospitals
  • Research Centers
  • Diagnostic Laboratories
  • Point of Care

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Hepatitis E Diagnostic Tests Market Forecast Report, 2019-2027

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of hepatitis E diagnostic tests market?

Hepatitis E diagnostic tests market was valued at US$ 47.8 Mn in 2018 and to reach US$ 67.9 Mn By 2027

What is the anticipated CAGR of the hepatitis E diagnostic tests market in the forecast period?

Hepatitis E diagnostic tests market is projected to expand at a CAGR of 4.5% from 2019 to 2027

What are the key driving factors for the growth of the hepatitis E diagnostic tests market?

Hepatitis E diagnostic tests market is driven by increase awareness among people related to the early diagnosis of HEV

Which region is expected to project the highest market share in the global hepatitis E diagnostic tests market?

Asia Pacific held the largest share of the global hepatitis E diagnostic tests market, and this region is expected to remain dominant during the forecast period

Who are the key players in the global hepatitis E diagnostic tests market?

Key players in the hepatitis E diagnostic tests market include altona Diagnostics GmbH, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Biokit S.A., Dia.Pro - Diagnostic Bioprobes s.r.l, F. Hoffmann-La Roche Ltd., Fast-track diagnostics Ltd

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hepatitis E Diagnostic Tests Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Hepatitis E Diagnostic Tests Market Analysis and Forecast, 2018–2030

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Value Chain Analysis

    5.2. Disease Overview

    5.3. Regulatory approval process

6. Global Hepatitis E Diagnostic Tests Market Analysis and Forecast, by Test Type

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Hepatitis E Diagnostic Tests Market Value Forecast, by Test Type, 2018–2030

        6.2.1. HEV IgM ELISA Test kits

        6.2.2. HEV IgG ELISA Test kits

        6.2.3. RT-PCR Test kits

        6.2.4. Others

    6.3. Global Hepatitis E Diagnostic Tests Market Attractiveness, by Test Type  

7. Global Hepatitis E Diagnostic Tests Market Analysis and Forecast, by End User

    7.1. Introduction & Definition

        7.1.1. Key Findings / Developments

    7.2. Global Hepatitis E Diagnostic Tests Market Value Forecast, by End User, 2018–2030

        7.2.1. Hospitals

        7.2.2. Diagnostic Laboratories

        7.2.3. Research Centers

        7.2.4. Point of Care

    7.3. Global Hepatitis E Diagnostic Tests Market Attractiveness, by End User

8. Global Hepatitis E Diagnostic Tests Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Global Hepatitis E Diagnostic Tests Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. North America Hepatitis E Diagnostic Tests Market Attractiveness, by Region

9. North America Hepatitis E Diagnostic Tests Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. North America Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

        9.2.1. HEV IgM ELISA Test kits

        9.2.2. HEV IgG ELISA Test kits

        9.2.3. RT-PCR Test kits

        9.2.4. Others

    9.3. North America Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by End User, 2018–2030

        9.3.1. Hospitals

        9.3.2. Diagnostic Laboratories

        9.3.3. Research Centers

        9.3.4. Point of Care

    9.4. North America Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Country, 2018–2030

        9.4.1. U.S.

        9.4.2. Canada

    9.5. North America Hepatitis E Diagnostic Tests Market Attractiveness Analysis

        9.5.1. By Test Type

        9.5.2. By End User

        9.5.3. By Country

10. Europe Hepatitis E Diagnostic Tests Market Analysis and Forecast

    10.1. Europe Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

        10.1.1. HEV IgM ELISA Test kits

        10.1.2. HEV IgG ELISA Test kits

        10.1.3. RT-PCR Test kits

        10.1.4. Others  

    10.2. Europe Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by End User, 2018–2030

        10.2.1. Hospitals

        10.2.2. Diagnostic Laboratories

        10.2.3. Research Centers

        10.2.4. Point of Care

    10.3. Europe Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        10.3.1. Germany

        10.3.2. U.K.

        10.3.3. France

        10.3.4. Spain

        10.3.5. Italy

        10.3.6. Rest of Europe

    10.4. Europe Hepatitis E Diagnostic Tests Market Attractiveness Analysis

        10.4.1. By Test Type

        10.4.2. By End User

        10.4.3. By Country/Sub-region

11. Asia Pacific Hepatitis E Diagnostic Tests Market Analysis and Forecast

    11.1. Asia Pacific Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

        11.1.1. HEV IgM ELISA Test kits

        11.1.2. HEV IgG ELISA Test kits

        11.1.3. RT-PCR Test kits

        11.1.4. Others  

    11.2. Asia Pacific Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by End User, 2018–2030

        11.2.1. Hospitals

        11.2.2. Diagnostic Laboratories

        11.2.3. Research Centers

        11.2.4. Point of Care

    11.3. Asia Pacific Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        11.3.1. China

        11.3.2. Japan

        11.3.3. India

        11.3.4. Australia & New Zealand

        11.3.5. Rest of Asia Pacific

    11.4. Asia Pacific Hepatitis E Diagnostic Tests Market Attractiveness Analysis

        11.4.1. By Test Type

        11.4.2. By End User

        11.4.3. By Country/Sub-region

12. Latin America Hepatitis E Diagnostic Tests Market Analysis and Forecast

    12.1. Latin America Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

        12.1.1. HEV IgM ELISA Test kits

        12.1.2. HEV IgG ELISA Test kits

        12.1.3. RT-PCR Test kits

        12.1.4. Others

    12.2. Latin America Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by End User, 2018–2030

        12.2.1. Hospitals

        12.2.2. Diagnostic Laboratories

        12.2.3. Research Centers

        12.2.4. Point of Care

    12.3. Latin America Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        12.3.1. Brazil

        12.3.2. Mexico

        12.3.3. Rest of Latin America Latin America

    12.4. Latin America Hepatitis E Diagnostic Tests Market Attractiveness Analysis

        12.4.1. By Test Type

        12.4.2. By End User

        12.4.3. By Country/Sub-region

13. Middle East & Africa Hepatitis E Diagnostic Tests Market Analysis and Forecast

        13.1.1.  

    13.2. Middle East & Africa Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

        13.2.1. HEV IgM ELISA Test kits

        13.2.2. HEV IgG ELISA Test kits

        13.2.3. RT-PCR Test kits

        13.2.4. Others

    13.3. Middle East & Africa Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by End User, 2018–2030

        13.3.1. Hospitals

        13.3.2. Diagnostic Laboratories

        13.3.3. Research Centers

        13.3.4. Point of Care

    13.4. Middle East & Africa Hepatitis E Diagnostic Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Middle East & Africa Hepatitis E Diagnostic Tests Market Attractiveness Analysis

        13.5.1. By Test Type

        13.5.2. By End User

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by Tier and Size of companies)

    14.2. Market Share / Position Analysis, by Company (2018)

    14.3. Competitive Business Strategies

    14.4. Company Profiles

        14.4.1. altona Diagnostics GmbH

            14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.1.2. Growth Strategies

            14.4.1.3. SWOT Analysis

        14.4.2. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

            14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.2.2. Growth Strategies

            14.4.2.3. SWOT Analysis

        14.4.3. Biokit S.A.

            14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.3.2. Growth Strategies

            14.4.3.3. SWOT Analysis

        14.4.4. Dia.Pro - Diagnostic Bioprobes s.r.l

            14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.4.2. Growth Strategies

            14.4.4.3. SWOT Analysis

        14.4.5. F. Hoffmann-La Roche Ltd.

            14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.5.2. Growth Strategies

            14.4.5.3. SWOT Analysis

        14.4.6. Fast-track diagnostics Ltd.

            14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.6.2. Growth Strategies

            14.4.6.3. SWOT Analysis

        14.4.7. Fortress Diagnostics Limited

            14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.7.2. Growth Strategies

            14.4.7.3. SWOT Analysis

        14.4.8. Mikrogen GmBH

            14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.8.2. Growth Strategies

            14.4.8.3. SWOT Analysis

        14.4.9. MP Biomedicals, LLC.

            14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.9.2. Growth Strategies

            14.4.9.3. SWOT Analysis

        14.4.10. Primerdesign Ltd.

            14.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.10.2. Growth Strategies

            14.4.10.3. SWOT Analysis

List of Tables

Table 01: Global Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016–2024

Table 02: Global Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-user, 2016–2024

Table 03: Global Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Region, 2016–2024

Table 04: North America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016–2024

Table 05: North America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-User, 2016–2024

Table 06: North America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016–2024

Table 07: Europe Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016–2024

Table 08: Europe Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-user, 2016–2024

Table 09: Europe Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016–2024

Table 10: Asia Pacific Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016–2024

Table 11: Asia Pacific Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-user, 2016–2024

Table 12: Asia Pacific Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016–2024

Table 13: Latin America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016–2024

Table 14: Latin America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-User, 2016–2024

Table 15: Latin America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016–2024

Table 16: Middle East & Africa Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016–2024

Table 17: Middle East & Africa Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-User, 2016–2024

Table 18: Middle East & Africa Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016–2024

List of Figures

Figure 1: Global Hepatitis E Diagnostic Tests Market Size (US$ Mn) and Forecast, 2016–2024

Figure 02: Global Market Value Share, by Test Type (2016)

Figure 03: Global Market Value Share, by End-user (2016)

Figure 04: Global Market Value Share, by Region (2016)

Figure 05: Global Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024

Figure 06: Global ELISA HEV IgM Test kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024

Figure 07: Global ELISA HEV IgG Test kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024

Figure 08: Global ELISA RT-PCR Test kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024

Figure 09: Global Others Test kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024

Figure 10: Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015

Figure 11: Global Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-user, 2015 and 2024

Figure 12: Global Hospitals Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024

Figure 13: Global Diagnostic Laboratories Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024

Figure 14: Global Research Centers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024

Figure 15: Global Point of Care Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2024

Figure 16: Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-user, 2015

Figure 17: Global Hepatitis E Diagnostic Tests Market Revenue, US$ Mn, 2014–2024

Figure 18: Global Hepatitis E Diagnostic Tests Market Value Share Analysis, by Region, 2015 and 2024

Figure 19: Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Region, 2015

Figure 20: North America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014–2024

Figure 21: North America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015

Figure 22: North America Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024

Figure 23: North America Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-User, 2015 and 2024

Figure 24: North America Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024

Figure 25: North America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015

Figure 26: North America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-User, 2015

Figure 27: Europe Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014–2024

Figure 28: Europe Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015

Figure 29: Europe Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024

Figure 30: Europe Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-user, 2015 and 2024

Figure 31: Europe Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024

Figure 32: Europe Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015

Figure 33: Europe Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-user, 2015

Figure 34: Asia Pacific Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014–2024

Figure 35: Asia Pacific Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015

Figure 36: Asia Pacific Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024

Figure 37: Asia Pacific Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-user, 2015 and 2024

Figure 38: Asia Pacific Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024

Figure 39: Asia Pacific Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015

Figure 40: Asia Pacific Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-user, 2015

Figure 41: Latin America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014–2024

Figure 42: Latin America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015

Figure 43: Latin America Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024

Figure 44: Latin America Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-User, 2015 and 2024

Figure 45: Latin America Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024

Figure 46: Latin America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015

Figure 47: Latin America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-User, 2015

Figure 48: Middle East & Africa Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014–2024

Figure 49: Middle East & Africa Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015

Figure 50: Middle East & Africa Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024

Figure 51: Middle East & Africa Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-User, 2015 and 2024

Figure 52: Middle East & Africa Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024

Figure 53: Middle East & Africa Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015

Figure 54: Middle East & Africa Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-User, 2015

Figure 55: Global Hepatitis E Diagnostic Tests Market Share Analysis, by Company

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

496

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved